Author

Kaitlyn Walsh

University of Colorado Anschutz

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Assay:DNA methylation· 1 Approach:experimental assay· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Andrew Day· 2 shared Doreen N. PalsgroveiD· 2 shared Eleanor M. DowelliD· 2 shared Richard C. WangiD· 2 shared Austin Witt· 1 shared Breelyn Wilky· 1 shared Calvin Hosler· 1 shared Claire D. JamesiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMolecular Biology

Andrew Day

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Regulation and Function of the HPV16 CircE7 RNA

Eunice E. Lee, Yihui Huang, Eleanor M. Dowell, Kaitlyn Walsh, Calvin Hosler, Austin Witt, Odera Ifeacho, Doreen N. Palsgrove, Andrew Day, Claire D. James, Richard C. Wang

This study investigates the regulation and function of HPV16 circE7 RNA, showing that m6A modification and IRES-like motifs are critical for its formation and translation, impacting viral replication and transformation.

Journal of Virology · Sep 17, 2026Peer-reviewedMolecular Biology

Subclonal IDH1/2 Mutations as a Targetable Vulnerability in Vascular Tumors

Dong-Min Yu, E L Lee, Gabriel J. Starrett, Zili Zhai, Eleanor M. Dowell, Kaitlyn Walsh, Andrew Day, Doreen N. Palsgrove, Justin Bishop, Dylan M. Marchione, Maryam Asgari, Stephen S. Chung, W.L. High, Joyce M. C. Teng, Josh Wissell, , Richard C Wang

This study identifies low-variant allele frequency IDH1/2 mutations in sporadic angiosarcoma and shows they drive tumorigenesis through non-cell-autonomous mechanisms, responding to ivosidenib treatment.

bioRxiv · May 17, 2026 · PreprintCancer Biology